Patrick F. Smith, PRESIDENT, DRUG Development SOLUTIONS at Certara, Inc. (CERT), sold 24,431 shares at $16.77 ($411K) on 2024-04-02, disclosed to the SEC on 2024-04-04.
Scheduled sale ($411k) by PRESIDENT, DRUG Development SOLUTIONS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.75 | 3,024 | $51K | 12.3% |
| 2 | $16.76 | 5,264 | $88K | 21.5% |
| 3 | $16.76 | 5,264 | $88K | 21.5% |
| 4 | $16.77 | 4,740 | $79K | 19.3% |
| 5 | $16.77 | 4,740 | $79K | 19.3% |
| 6 | $17.67 | 328 |
| $6K |
| 1.4% |
| 7 | $17.72 | 649 | $12K | 2.8% |
| 8 | $17.77 | 422 | $7K | 1.8% |
| Total | $16.82 avg | 24,431 | $411K | 100% |
| Filing → |
| CERT | SELL | 2023-06-06 | $823K | — | Filing → |
| CERT | SELL | 2022-11-14 | $32K | — | Filing → |
| CERT | SELL | 2022-08-18 | $177K | — | Filing → |